From: Effects of karanjin on cell cycle arrest and apoptosis in human A549, HepG2 and HL-60 cancer cells
Cell line | Group | Apoptosis distribution (%) in cells | |||
---|---|---|---|---|---|
Viable cell | Early apoptosis | Late apoptosis | Necrosis | ||
A549 | control | 91.97 ± 0.34 | 1.59 ± 0.41 | 6.08 ± 0.36 | 0.35 ± 0.11 |
4.0 µM | 76.13 ± 5.99* | 6.75 ± 1.04** | 16.80 ± 5.08* | 0.33 ± 0.02 | |
6.0 µM | 61.03 ± 0.99** | 9.03 ± 1.27** | 29.47 ± 1.08** | 0.44 ± 0.12 | |
8.0 µM | 47.03 ± 1.43** | 9.15 ± 0.92** | 35.33 ± 1.72** | 8.50 ± 0.92 | |
HepG2 | control | 89.53 ± 1.37 | 1.16 ± 0.08 | 8.54 ± 0.83 | 0.79 ± 0.52 |
1.25 µM | 88.10 ± 1.21 | 1.68 ± 0.15** | 9.29 ± 1.56 | 0.93 ± 0.29 | |
2.5 µM | 80.83 ± 2.03** | 2.70 ± 0.26** | 15.40 ± 2.32** | 1.07 ± 0.35 | |
5.0 µM | 26.33 ± 0.90** | 23.23 ± 0.29** | 48.43 ± 0.90** | 2.02 ± 0.21 | |
HL-60 | control | 93.37 ± 0.33 | 1.10 ± 0.06 | 5.31 ± 0.22 | 0.23 ± 0.04 |
2.0 µM | 82.77 ± 0.99** | 1.72 ± 0.21** | 14.97 ± 0.70** | 0.58 ± 0.07 | |
4.0 µM | 56.33 ± 1.11** | 2.38 ± 0.36** | 39.40 ± 1.13** | 1.93 ± 0.37 | |
6.0 µM | 43.00 ± 1.02** | 2.24 ± 0.59* | 53.53 ± 1.13** | 1.25 ± 0.11 |